Please login to the form below

Not currently logged in
Email:
Password:

Roche teams up with Californian university

Roche has signed a deal with the University of California Los Angeles to work together on biomarker discovery projects

Roche has signed a deal with the University of California Los Angeles (UCLA) that will bring stem cell and cancer researchers together with leading-edge technologies to drive research capabilities and further the understanding of complex disease.

The technologies, including the latest generation microarray systems from Roche NimbleGen, high-throughput screening instruments, genetic expression profilers and exome sequencing technologies will provide scientists with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and UCLA's Jonsson Comprehensive Cancer Center with technology directly from Roche's research and development pipeline.

Robert Yates, head of Roche Applied Science, said: "Our focus is to provide the scientific community with cutting-edge genomic tools that can rapidly advance their research. This collaboration is an innovative approach to working closely with leading institutes, such as UCLA, at an early stage of research in the pursuit of new predictive biomarkers."

"By working together at an early stage, we can optimise the technologies and provide the necessary support to improve detection and analysis, and ultimately, the success rate of biomarker discovery."

Under the agreement, Roche will also provide UCLA with advanced reagent, technologies and bioinformatics support to be used in the pursuit of discovering new predictive biomarkers, which will be used as targets for future therapeutics and diagnostics for a host of diseases.

UCLA researchers will submit project applications for research using the new technology and an advisory committee comprised of Roche and UCLA scientists will review and select the projects that propose the best use of the technology and which are most likely to succeed.

13th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics